ValuEngine upgraded shares of Celcuity (NASDAQ:CELC) from a hold rating to a buy rating in a research note issued to investors on Friday.

A number of other equities analysts have also issued reports on the stock. HC Wainwright started coverage on shares of Celcuity in a research report on Tuesday, November 20th. They set a buy rating and a $36.00 target price on the stock. Zacks Investment Research raised shares of Celcuity from a hold rating to a buy rating and set a $26.00 target price on the stock in a research report on Thursday, February 28th.

Shares of CELC stock opened at $20.07 on Friday. Celcuity has a 1 year low of $13.16 and a 1 year high of $31.00. The firm has a market cap of $209.18 million, a P/E ratio of -27.12 and a beta of 0.24.

Institutional investors and hedge funds have recently bought and sold shares of the business. Strs Ohio boosted its stake in Celcuity by 112.5% during the fourth quarter. Strs Ohio now owns 1,700 shares of the company’s stock worth $40,000 after buying an additional 900 shares in the last quarter. Kessler Investment Group LLC acquired a new stake in Celcuity during the fourth quarter worth $115,000. Acadian Asset Management LLC boosted its stake in Celcuity by 58.3% during the third quarter. Acadian Asset Management LLC now owns 4,797 shares of the company’s stock worth $138,000 after buying an additional 1,766 shares in the last quarter. Teachers Advisors LLC acquired a new stake in Celcuity during the third quarter worth $207,000. Finally, California Public Employees Retirement System acquired a new stake in Celcuity during the second quarter worth $248,000. Hedge funds and other institutional investors own 22.04% of the company’s stock.

About Celcuity

Celcuity Inc, a cellular analysis company, discovers cancer sub-types and commercializes diagnostic tests to enhance the response rates of cancer patients treated with targeted therapies in the United States. The company is developing CELx tests to diagnose two new sub-types of HER2-negative breast cancer.

Recommended Story: Candlestick

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.